AHL
HURA

Abel Hall LLC’s TuHURA Biosciences HURA Stock Holding History

Abel Hall LLC’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9K Buy
10,661
+634
+6% +$1.48K ﹤0.01% 937
2026
Q1 		$17.9K Buy
+10,027
New +$12.3K ﹤0.01% 794

Other funds holding HURA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return

Abel Hall LLC's HURA Position: Q2 2026 in Review

Abel Hall LLC increased its TuHURA Biosciences (HURA) stake by 6.3% in Q2 2026, buying an estimated $1.48K and bringing the position to 10,661 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Abel Hall LLC first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Abel Hall LLC held 10,661 shares of TuHURA Biosciences worth $24.9K as of Q2 2026.
  • Abel Hall LLC bought 634 TuHURA Biosciences shares in Q2 2026, an estimated $1.48K.
  • TuHURA Biosciences made up ﹤0.01% of Abel Hall LLC's portfolio in Q2 2026, its #937 holding.
  • Abel Hall LLC first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.